Astera Labs (NASDAQ:ALAB) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen downgraded shares of Astera Labs (NASDAQ:ALAB) from a buy rating to a hold rating in a report released on Friday morning.

Several other equities research analysts also recently weighed in on the company. Cowen started coverage on Astera Labs in a report on Tuesday, September 30th. They issued a “hold” rating on the stock. Susquehanna upped their price objective on Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a research report on Thursday, August 7th. Jefferies Financial Group lifted their target price on Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, July 22nd. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a research note on Tuesday, September 2nd. Finally, Barclays reaffirmed an “overweight” rating and issued a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $159.83.

Astera Labs Trading Down 4.2%

Astera Labs stock opened at $200.74 on Friday. The firm has a 50-day moving average price of $189.83 and a 200-day moving average price of $119.85. The firm has a market capitalization of $33.37 billion, a PE ratio of 358.46, a price-to-earnings-growth ratio of 5.09 and a beta of 1.43. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same period in the prior year, the firm posted $0.13 EPS. The firm’s revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, sell-side analysts predict that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 152,517 shares of the stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.33, for a total value of $25,978,220.61. Following the completion of the sale, the chief executive officer directly owned 450,001 shares in the company, valued at approximately $76,648,670.33. This trade represents a 25.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Sanjay Gajendra sold 280,000 shares of the business’s stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the sale, the chief operating officer owned 5,525,545 shares in the company, valued at $939,453,160.90. The trade was a 4.82% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,492,036 shares of company stock valued at $232,607,552. 12.50% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in shares of Astera Labs by 29.6% in the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after buying an additional 2,751,747 shares during the last quarter. Alliancebernstein L.P. increased its position in shares of Astera Labs by 114.2% in the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock valued at $501,289,000 after acquiring an additional 4,478,741 shares during the period. Atreides Management LP raised its stake in Astera Labs by 153.3% in the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after acquiring an additional 2,815,614 shares during the last quarter. State Street Corp raised its stake in Astera Labs by 39.3% in the 2nd quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after acquiring an additional 604,363 shares during the last quarter. Finally, Fred Alger Management LLC lifted its position in Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after acquiring an additional 179,638 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.